References
Andersen M, Kragstrup J, Sondergaard J (2006) How conducting a clinical trialaffects physicians' guideline adherence and drug preferences. Journal of the Am Med Assoc 295:2759–2764
Banaschewski T, Coghill D, Santosh P, Zuddas A, Ascherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E (2006) Long-acting medications for the hyperkinetic disorders: A systematic review and European guideline. Eur Child Adolesc Psychiatry (in press)
Becker A, Steinhausen HC, Baldursson G, Dalsgaard S, Lorenzo MJ, Ralston SJ, Döpfner M, Rothenberger A and the ADORE study group (2006) Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European study. Eur Child Adolesc Psychiatry 15(Suppl 1):56–62
Coghill D, Spiel G, Baldursson G, Döpfner M, Lorenzo MJ, Ralston S, Rothenberger A and the ADORE study group (2006) Which factors impact on clinician-rated impairment in children with ADHD? Eur Child Adolesc Psychiatry 15(Suppl 1):30–37
Döpfner M, Breuer D, Schürmann S, Wolff Metternich T, Rademacher C, Lehmkuhl G (2004) Effectiveness of an adaptive multimodal treatment in children with Attention Deficit Hyperactivity Disorder – global outcome. European Child and Adolescent Psychiatry 13(Suppl 1):117–129
Döpfner M, Steinhausen HC, Coghill D, Dalsgaard S, Poole L, Ralston SJ, Rothenberger A and the ADORE study group (2006) Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study. Eur Child Adolesc Psychiatry 15(Suppl 1):46–55
Meyer R (2006) Anwendungsbeobachtungen – Verführerisches Marketinginstrument. (Observational studies – a seductive marketing instrument). Deutsches Ärzteblatt 103(26):B1529
MTA Study Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073–1086
MTA Study Group (2004) National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 113:754–761
MTA Study Group (2004) National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113:762–769
Nøvik TS, Hervas A, Ralston SJ, Dalsgaard S, Pereira RR, Lorenzo MJ and the ADORE study group. Influence of gender on Attention-Deficit/Hyperactivity Disorder in Europe – ADORE. Eur Child Adolesc Psychiatry 15(Suppl 1):15–24
Pine DS (2005) Editorial: Where have all the clinical trials gone. J Child Psychol Psychiatry 46:449–450
Preuss U, Ralston SJ, Baldursson G, Falissard B, Lorenzo MJ, Pereira RR, Valsveld L, Coghill D and the ADORE study group (2006) Study design, baseline characteristics and interventions in a cross-cultural framework: results from the ADORE study. Eur Child Adolesc Psychiatry 15(Suppl 1):4–13
Ralston SJ, Lorenzo MJ, ADORE Study Group (2004) ADORE–Attention-Deficit Hyperactivity Disorder Observational Research in Europe. Eur Child Adoles Psychiatry 13(Suppl 1):36–42
Riley AW, Coghill D, Forrest CB, Lorenzo MJ, Ralston SJ, Spiel G and the ADORE study group (2006) Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition. Eur J Child Adolescent Psychiatry 15(Suppl 1):63–71
Riley AW, Lyman LM, Spiel G, Döpfner M, Lorenzo MJ, Ralston SJ and the ADORE study group (2006) The Family Strain Index (FSI). Reliability, validity and factor structure of a brief questionnaire for families of children with ADHD. Eur Child Adolesc Psychiatry 15(Suppl 1):72–78
Riley AW, Spiel G, Coghill D, Döpfner M, Falissard B, Lorenzo MJ, Preuss U, Ralston SJ and the ADORE study group. Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur Child Adolesc Psychiatry 15(Suppl 1):38–45
Steinhausen HC, Nøvick TS, Baldursson G, Curatolo P, Lorenzo MJ, Pereira RR, Ralston SJ, Rothenberger A and the ADORE study group (2006) Co-existing psychiatric problems in ADHD in the ADORE cohort. Eur Child Adolesc Psychiatry 15(Suppl 1):25–29
Taylor E, Döpfner M, Sergeant J,Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder – first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):7–30
Taylor E, Sergeant J, Döpfner M, Gunning B, Overmeyer S, Möbius HJ, Eissert HG (1998) Clinical Guidelines for hyperkinetic disorder. Eur Child Adolesc Psychiatry 54:329–336
Willich SN (2006) Randomisierte kontrollierte Studien: Pragmatische Ansätze erforderlich. (Randomized controlled trials – pragmatic approaches required). Deutsches Ärzteblatt 103(39):B2185–B2189
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s00787-009-0752-x.
Rights and permissions
About this article
Cite this article
Rothenberger, A., Coghill, D., Döpfner, M. et al. Naturalistic-observational studies in the framework of ADHD health care. Eur Child Adolesc Psychiatry 15 (Suppl 1), i1–i3 (2006). https://doi.org/10.1007/s00787-006-1001-1
Issue Date:
DOI: https://doi.org/10.1007/s00787-006-1001-1